As of June 2022 Travere Therapeutics has a market cap of $1.54 Billion. This makes Travere Therapeutics the world's 3794th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $1.53 B | -19.16% |
2021 | $1.90 B | 33.46% |
2020 | $1.42 B | 132.74% |
2019 | $0.61 B | -34.68% |
2018 | $0.93 B | 13.1% |
2017 | $0.82 B | 15.95% |
2016 | $0.71 B | 1.54% |
2015 | $0.70 B | 120.63% |
2014 | $0.31 B | 147.33% |
2013 | $0.12 B | 329.81% |
2012 | $0.02 B | 31170.25% |
2011 | $0.09 M |
On Jun 28th, 2022 the market cap of Travere Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() OPKO Health
OPK | $1.72 B | 12.24% | ๐บ๐ธ USA |
![]() Onconova Therapeutics ONTX | $0.02 B | -98.22% | ๐บ๐ธ USA |